Skip to content

Spectacle Lens Visual Acuity Assessments Study

Spectacle Lenses Visual Acuity Assessments Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05650190
Acronym
CEDAR
Enrollment
51
Registered
2022-12-14
Start date
2022-12-08
Completion date
2026-12-31
Last updated
2026-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Juvenile Myopia, Myopia, Myopia Progression

Brief summary

This is a two-arm parallel group, non-dispensing study. Participants will be existing active CYPRESS Extension (CPRO-1802-002) subjects. Subjects will undergo additional visual performance assessments.

Interventions

Use of single vision, impact resistant spectacle lenses may reduce the rate of progression of juvenile myopia

Single vision, impact resistant spectacle lenses

Sponsors

SightGlass Vision, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
9 Years to 14 Years
Healthy volunteers
Yes

Inclusion criteria

* Existing subject from the CYPRESS Extension study (CPRO-1802-002) * Ability to comply with study assessments * The subject's parent(s) or legal guardian(s) must read, understand and sign the Statement of Informed Consent and receive a fully executed coy of the form

Exclusion criteria

* Any current ocular infection, inflammation or irritation likely to affect vision

Design outcomes

Primary

MeasureTime frameDescription
Visual Acuity15 minutesReading Speed (maximum words per minute)

Secondary

MeasureTime frameDescription
Near Visual Acuity with Glare15 minutesMean and Standard Deviation at 15 minutes (short duration test)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 6, 2026